PL373085A1 - Przedleki pochodnych imidazolu do stosowania jakoinhibitory pompy protonowej w leczeniu np. wrzodów trawiennych - Google Patents
Przedleki pochodnych imidazolu do stosowania jakoinhibitory pompy protonowej w leczeniu np. wrzodów trawiennychInfo
- Publication number
- PL373085A1 PL373085A1 PL03373085A PL37308503A PL373085A1 PL 373085 A1 PL373085 A1 PL 373085A1 PL 03373085 A PL03373085 A PL 03373085A PL 37308503 A PL37308503 A PL 37308503A PL 373085 A1 PL373085 A1 PL 373085A1
- Authority
- PL
- Poland
- Prior art keywords
- prodrugs
- treatment
- proton pump
- imidazole derivatives
- pump inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002175086 | 2002-06-14 | ||
| JP2003041085 | 2003-02-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL373085A1 true PL373085A1 (pl) | 2005-08-08 |
Family
ID=29738411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03373085A PL373085A1 (pl) | 2002-06-14 | 2003-06-13 | Przedleki pochodnych imidazolu do stosowania jakoinhibitory pompy protonowej w leczeniu np. wrzodów trawiennych |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7410981B2 (pl) |
| EP (2) | EP1514870A4 (pl) |
| JP (1) | JPWO2003106429A1 (pl) |
| KR (1) | KR20050009751A (pl) |
| CN (1) | CN1678315A (pl) |
| AR (1) | AR040221A1 (pl) |
| AT (1) | ATE437642T1 (pl) |
| AU (2) | AU2003242390A1 (pl) |
| BR (1) | BR0311801A (pl) |
| CA (2) | CA2489470A1 (pl) |
| DE (1) | DE60328603D1 (pl) |
| IL (1) | IL165562A0 (pl) |
| MX (1) | MXPA04012396A (pl) |
| NO (1) | NO20050141L (pl) |
| OA (1) | OA12867A (pl) |
| PE (1) | PE20040563A1 (pl) |
| PL (1) | PL373085A1 (pl) |
| TW (1) | TW200307544A (pl) |
| WO (2) | WO2003105845A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7176319B2 (en) | 2004-04-28 | 2007-02-13 | Hetero Drugs Limited | Process for substituted sulfoxides |
| CA2784881C (en) | 2005-02-25 | 2016-02-09 | Takeda Pharmaceutical Company Limited | Method for producing granules |
| KR101148399B1 (ko) * | 2005-06-22 | 2012-05-23 | 일양약품주식회사 | 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물 |
| US20100317689A1 (en) * | 2006-09-19 | 2010-12-16 | Garst Michael E | Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety |
| US20080103169A1 (en) | 2006-10-27 | 2008-05-01 | The Curators Of The University Of Missouri | Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same |
| EP2252274A4 (en) | 2008-02-20 | 2011-05-11 | Univ Missouri | COMPOSITION COMPRISING A COMBINATION OF OMEPRAZOLE AND LANSOPRAZOLE, AND A BUFFER AGENT, AND METHODS OF USING THE SAME |
| US8722720B2 (en) | 2009-10-28 | 2014-05-13 | Newlink Genetics Corporation | Imidazole derivatives as IDO inhibitors |
| US8916563B2 (en) | 2010-07-16 | 2014-12-23 | The Trustees Of Columbia University In The City Of New York | Aldose reductase inhibitors and uses thereof |
| WO2016172436A1 (en) * | 2015-04-23 | 2016-10-27 | Temple University-Of The Commonwealth System Of Higher Education | Polycationic amphiphiles and polymers thereof as antimicrobial agents and methods using same |
| EP3352754B1 (en) | 2016-06-21 | 2020-09-02 | The Trustees of Columbia University in the City of New York | Aldose reductase inhibitors and methods of use thereof |
| US11111216B2 (en) | 2016-10-26 | 2021-09-07 | Temple University-Of The Commonwealth System Of Higher Education | Polycationic amphiphiles as antimicrobial agents and methods using same |
| AU2018307964B2 (en) | 2017-07-28 | 2023-11-16 | Applied Therapeutics Inc. | Compositions and methods for treating galactosemia |
| JP7404561B2 (ja) * | 2020-06-17 | 2023-12-25 | イルドン ファーマシューティカル カンパニー リミテッド | 新規な酸分泌抑制剤及びその用途 |
| IT202200001022A1 (it) * | 2022-01-21 | 2023-07-21 | Exo Lab Italia | Composti farmaceutici ibridi ottenuti mediante coniugazione di un inibitore delle pompe protoniche e un inibitore delle anidrasi carboniche |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE416649B (sv) | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
| SE8300736D0 (sv) | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
| KR890000387B1 (ko) | 1984-09-24 | 1989-03-16 | 디 엎존 캄파니 | 2-(피리딜알켄술 피닐)벤즈 이미드아졸류의 n-치환 유도체의 제조방법 |
| IL76839A (en) | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
| SE8505112D0 (sv) | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
| US4965269A (en) | 1989-12-20 | 1990-10-23 | Ab Hassle | Therapeutically active chloro substituted benzimidazoles |
| US5614549A (en) * | 1992-08-21 | 1997-03-25 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
| DE19832060C2 (de) * | 1998-07-16 | 2000-07-06 | Siemens Ag | Doppelbare Prozessoreinrichtung |
| US6542966B1 (en) * | 1998-07-16 | 2003-04-01 | Intel Corporation | Method and apparatus for managing temporal and non-temporal data in a single cache structure |
| US6093734A (en) | 1998-08-10 | 2000-07-25 | Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin | Prodrugs of proton pump inhibitors |
| PL352834A1 (pl) * | 1999-04-09 | 2003-09-08 | Abbott Gmbh & Co.Kg | Proleki inhibitorów trombiny |
| US6765019B1 (en) * | 1999-05-06 | 2004-07-20 | University Of Kentucky Research Foundation | Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| AU2001271908A1 (en) * | 2000-07-07 | 2002-01-21 | Neotherapeutics, Inc. | Methods for treatment of disease-induced peripheral neuropathy and related conditions |
| AU2001294228A1 (en) | 2000-10-12 | 2002-04-22 | Takeda Chemical Industries Ltd. | Benzimidazole compounds, process for producing the same and use thereof |
| CN101671335A (zh) * | 2001-05-31 | 2010-03-17 | 梅达莱克斯公司 | 细胞毒素、其有用的前体药物、连接基团和稳定剂 |
| US20040248941A1 (en) | 2001-09-25 | 2004-12-09 | Keiji Kamiyama | Benzimidazone compound, process for producing the same, and use thereof |
-
2003
- 2003-06-13 CA CA002489470A patent/CA2489470A1/en not_active Abandoned
- 2003-06-13 KR KR10-2004-7020371A patent/KR20050009751A/ko not_active Application Discontinuation
- 2003-06-13 EP EP03733425A patent/EP1514870A4/en not_active Withdrawn
- 2003-06-13 PE PE2003000593A patent/PE20040563A1/es not_active Application Discontinuation
- 2003-06-13 AR ARP030102114A patent/AR040221A1/es not_active Application Discontinuation
- 2003-06-13 DE DE60328603T patent/DE60328603D1/de not_active Expired - Lifetime
- 2003-06-13 US US10/517,633 patent/US7410981B2/en not_active Expired - Fee Related
- 2003-06-13 CA CA002489361A patent/CA2489361A1/en not_active Abandoned
- 2003-06-13 MX MXPA04012396A patent/MXPA04012396A/es not_active Application Discontinuation
- 2003-06-13 WO PCT/JP2003/007546 patent/WO2003105845A1/en active Application Filing
- 2003-06-13 AT AT03733426T patent/ATE437642T1/de not_active IP Right Cessation
- 2003-06-13 JP JP2004513262A patent/JPWO2003106429A1/ja active Pending
- 2003-06-13 TW TW092116056A patent/TW200307544A/zh unknown
- 2003-06-13 PL PL03373085A patent/PL373085A1/pl not_active Application Discontinuation
- 2003-06-13 WO PCT/JP2003/007545 patent/WO2003106429A1/ja active Application Filing
- 2003-06-13 US US10/517,847 patent/US20060293371A1/en not_active Abandoned
- 2003-06-13 AU AU2003242390A patent/AU2003242390A1/en not_active Abandoned
- 2003-06-13 AU AU2003242388A patent/AU2003242388A1/en not_active Abandoned
- 2003-06-13 EP EP03733426A patent/EP1513527B1/en not_active Expired - Lifetime
- 2003-06-13 CN CNA038188953A patent/CN1678315A/zh active Pending
- 2003-06-13 OA OA1200400327A patent/OA12867A/en unknown
- 2003-06-13 BR BR0311801-0A patent/BR0311801A/pt not_active IP Right Cessation
-
2004
- 2004-12-05 IL IL16556204A patent/IL165562A0/xx unknown
-
2005
- 2005-01-11 NO NO20050141A patent/NO20050141L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL165562A0 (en) | 2006-01-15 |
| US20060293371A1 (en) | 2006-12-28 |
| DE60328603D1 (de) | 2009-09-10 |
| US7410981B2 (en) | 2008-08-12 |
| WO2003105845A1 (en) | 2003-12-24 |
| EP1514870A4 (en) | 2006-08-23 |
| CN1678315A (zh) | 2005-10-05 |
| PE20040563A1 (es) | 2004-10-21 |
| NO20050141D0 (no) | 2005-01-11 |
| CA2489361A1 (en) | 2003-12-24 |
| EP1514870A1 (en) | 2005-03-16 |
| OA12867A (en) | 2006-09-15 |
| AR040221A1 (es) | 2005-03-16 |
| ATE437642T1 (de) | 2009-08-15 |
| US20050222210A1 (en) | 2005-10-06 |
| CA2489470A1 (en) | 2003-12-24 |
| WO2003106429A1 (ja) | 2003-12-24 |
| TW200307544A (en) | 2003-12-16 |
| KR20050009751A (ko) | 2005-01-25 |
| MXPA04012396A (es) | 2005-06-17 |
| AU2003242390A1 (en) | 2003-12-31 |
| AU2003242388A1 (en) | 2003-12-31 |
| NO20050141L (no) | 2005-01-27 |
| JPWO2003106429A1 (ja) | 2005-10-13 |
| EP1513527A1 (en) | 2005-03-16 |
| EP1513527B1 (en) | 2009-07-29 |
| BR0311801A (pt) | 2005-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20050141D0 (no) | Prodrugs av imidazolderivater for anvendelse som protonpumpeinhibitorer ved behandlingen av f.eks. peptisk ulcus | |
| AU2003213768A1 (en) | Use of benzimidazole analogs in the treatment of cell proliferation | |
| WO2010038086A3 (en) | P38 map kinase inhibitors | |
| EP1803709A4 (en) | PROTON PUMP INHIBITORS | |
| ZA200501677B (en) | Hydantoin derivatives and their use as TACE inhibitors. | |
| AU2003258441A1 (en) | System for performing proton therapy | |
| UA104731C2 (ru) | Ингибиторы р38 мар-киназ | |
| AU2003206785A1 (en) | Use of tyrosine kinase inhibitors for the treatment of inflammatory processes | |
| DK1318992T3 (da) | Imidazolderivater som Raf-kinaseinhibitorer | |
| AU2002306601A1 (en) | Under the counter water treatment system | |
| WO2007120333A3 (en) | Tetracyclic kinase inhibitors | |
| WO2005021544A3 (en) | N3-substituted imidazopyridine-derivatives as c-kit inhibitors | |
| EP1534278A4 (en) | NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD | |
| AU2002366796A1 (en) | Methods using proton pump inhibitors | |
| WO2003039545A3 (en) | Carboline derivatives as inhibitors of ikb in the treatment of multiple myeloma and others cancers | |
| NO20054053D0 (no) | Triazolforbindelser anvendbare i terapi. | |
| HK1072379A1 (en) | Annelated pyrrole compounds as proton pump inhibitors for treating ulcer | |
| TW200510398A (en) | Novel compounds | |
| GB0403165D0 (en) | Novel uses for proton pump inhibitors | |
| WO2004098599A3 (en) | Proton pump inhibitors for the treatment of lower abdominal disorders | |
| MXPA05003315A (es) | Un sistema de liberacion controlada que contiene temozolomida. | |
| TW200509921A (en) | Alkaline salts | |
| PL1663997T3 (pl) | 1H-azolilo-metylo-amidy, sposoby ich wytwarzania i ich zastosowanie jako inhibitorów nitryfikacji | |
| MY140194A (en) | Novel fusidic acid derivatives | |
| WO2005082337A3 (en) | Compositions comprising prodrugs of proton pump inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |